Return On Equity of CRISPR Therapeutics AG from 30 Jun 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CRISPR Therapeutics AG quarterly and annual Return On Equity in % history and change rate from 30 Jun 2017 to 30 Sep 2025.
  • CRISPR Therapeutics AG Return On Equity for the quarter ending 30 Sep 2025 was -26%, a 118% decline year-over-year.
  • CRISPR Therapeutics AG annual Return On Equity for 2024 was -18%, a 119% decline from 2023.
  • CRISPR Therapeutics AG annual Return On Equity for 2023 was -8%, a 73% increase from 2022.
  • CRISPR Therapeutics AG annual Return On Equity for 2022 was -32%, a 297% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

CRISPR Therapeutics AG Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26% -14% -118% 01 Jul 2025 30 Sep 2025
Q2 2025 -25% -11% -82% 01 Apr 2025 30 Jun 2025
Q1 2025 -20% -9% -74% 01 Jan 2025 31 Mar 2025
Q4 2024 -18% -10% -119% 01 Oct 2024 31 Dec 2024
Q3 2024 -12% +7% +37% 01 Jul 2024 30 Sep 2024
Q2 2024 -14% +8% +38% 01 Apr 2024 30 Jun 2024
Q1 2024 -12% +15% +57% 01 Jan 2024 31 Mar 2024
Q4 2023 -8% +23% +73% 01 Oct 2023 31 Dec 2023
Q3 2023 -19% +12% +38% 01 Jul 2023 30 Sep 2023
Q2 2023 -22% +5% +19% 01 Apr 2023 30 Jun 2023
Q1 2023 -27% -40% -311% 01 Jan 2023 31 Mar 2023
Q4 2022 -32% -48% -297% 01 Oct 2022 31 Dec 2022
Q3 2022 -31% -51% -263% 01 Jul 2022 30 Sep 2022
Q2 2022 -27% -51% -214% 01 Apr 2022 30 Jun 2022
Q1 2022 13% +40% 01 Jan 2022 31 Mar 2022
Q4 2021 16% +45% 01 Oct 2021 31 Dec 2021
Q3 2021 19% +40% 01 Jul 2021 30 Sep 2021
Q2 2021 24% +22% +923% 01 Apr 2021 30 Jun 2021
Q1 2021 -27% -34% -519% 01 Jan 2021 31 Mar 2021
Q4 2020 -29% -41% -347% 01 Oct 2020 31 Dec 2020
Q3 2020 -21% -18% -695% 01 Jul 2020 30 Sep 2020
Q2 2020 2% +54% 01 Apr 2020 30 Jun 2020
Q1 2020 7% +57% 01 Jan 2020 31 Mar 2020
Q4 2019 12% +60% 01 Oct 2019 31 Dec 2019
Q3 2019 -3% +38% +94% 01 Jul 2019 30 Sep 2019
Q2 2019 -51% -12% -30% 01 Apr 2019 30 Jun 2019
Q1 2019 -51% -16% -45% 01 Jan 2019 31 Mar 2019
Q4 2018 -48% -13% -38% 01 Oct 2018 31 Dec 2018
Q3 2018 -40% -15% -62% 01 Jul 2018 30 Sep 2018
Q2 2018 -40% -11% -40% 01 Apr 2018 30 Jun 2018
Q1 2018 -35% 01 Jan 2018 31 Mar 2018
Q4 2017 -35% 01 Oct 2017 31 Dec 2017
Q3 2017 -25% 01 Jul 2017 30 Sep 2017
Q2 2017 -28% 01 Apr 2017 30 Jun 2017

CRISPR Therapeutics AG Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -18% -10% -119% 01 Jan 2024 31 Dec 2024
2023 -8% +23% +73% 01 Jan 2023 31 Dec 2023
2022 -32% -48% -297% 01 Jan 2022 31 Dec 2022
2021 16% +45% 01 Jan 2021 31 Dec 2021
2020 -29% -41% -347% 01 Jan 2020 31 Dec 2020
2019 12% +60% 01 Jan 2019 31 Dec 2019
2018 -48% -13% -38% 01 Jan 2018 31 Dec 2018
2017 -35% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.